Trial Details
Not RecruitingBasic Information
| Clinical ID | c5080 |
|---|---|
| Identifier | EUCTR2018-001546-33-GB |
| Trial Title | IBD Biosimilar to Biosimilar Infliximab Switching Study - iBiSS v1.0 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Inflammatory Bowel Disease in particular Crohn's Disease and Ulcerative Colitis MedDRA version: 20.1.Level: PT.Classification code 10021972.Term: Inflammatory bowel disease.System Organ Class: 10017947 - Gastrointestina |
| Interventions | Trade Name: FlixabiProduct Name: FlixabiPharmaceutical Form: InfusionINN or Proposed INN: InfliximabCAS Number: 170277-31-3Concentration unit: mg milligram(s)Concentration type: equal |
Participant Information
| Sponsor | University Southampton Hospital NHS Foundation Trust |
|---|---|
| City | NULL |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |